In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all
current investors, traders, and shareholders of Aradigm Corporation
(NASDAQ:ARDM), General Motors Company (NYSE:GM), AT&T Inc.
(NYSE:T), Denbury Resources Inc. (NYSE:DNR), Novavax, Inc.
(NASDAQ:NVAX), and Immunomedics, Inc. (NASDAQ:IMMU), including
updated fundamental summaries, consolidated fiscal reporting, and
fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
ARDM DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ARDM
GM DOWNLOAD:
http://Fundamental-Markets.com/register/?so=GM
T DOWNLOAD:
http://Fundamental-Markets.com/register/?so=T
DNR DOWNLOAD:
http://Fundamental-Markets.com/register/?so=DNR
NVAX DOWNLOAD:
http://Fundamental-Markets.com/register/?so=NVAX
IMMU DOWNLOAD:
http://Fundamental-Markets.com/register/?so=IMMU
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Fundamental
Markets, available for free download at the links above, examine
Aradigm Corporation (NASDAQ:ARDM), General Motors Company
(NYSE:GM), AT&T Inc. (NYSE:T), Denbury Resources Inc.
(NYSE:DNR), Novavax, Inc. (NASDAQ:NVAX), and Immunomedics, Inc.
(NASDAQ:IMMU) on a fundamental level and outlines the overall
demand for their products and services in addition to an in-depth
review of the business strategy, management discussion, and overall
direction going forward. Several excerpts from the recently
released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. All
information in this release was accessed November 24th, 2017.
Please download the entire research report, free of charge, to
ensure you are reading all relevant material information. All
amounts in millions (except per share amounts).
-----------------------------------------
Aradigm Corporation (ARDM) REPORT OVERVIEW
Aradigm's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Aradigm reported revenue of $2.73 vs $0.05
(up 5,356%) and diluted earnings per share -$0.26 vs -$0.55. For
the twelve months ended December 31st, 2016 vs December 31st, 2015,
Aradigm reported revenue of $0.20 vs $23.43 (down 99.17%) and
diluted earnings per share -$2.23 vs -$1.17. Aradigm is expected to
report earnings on March 27th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was -$0.54. The estimated EPS forecast for
the next fiscal year is -$0.40 and is expected to report on March
27th, 2018.
To read the full Aradigm Corporation (ARDM) report, download it
here:
http://Fundamental-Markets.com/register/?so=ARDM
-----------------------------------------
General Motors Company (GM) REPORT OVERVIEW
General Motors' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, General Motors reported revenue of
$33,623.00 vs $38,889.00 (down 13.54%) and diluted earnings per
share -$2.03 vs $1.76. For the twelve months ended December 31st,
2016 vs December 31st, 2015, General Motors reported revenue of
$166,380.00 vs $152,356.00 (up 9.20%) and diluted earnings per
share $6.00 vs $5.91 (up 1.52%). General Motors is expected to
report earnings on February 6th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was $1.28. The estimated EPS forecast for
the next fiscal year is $5.84 and is expected to report on February
6th, 2018.
To read the full General Motors Company (GM) report, download it
here:
http://Fundamental-Markets.com/register/?so=GM
-----------------------------------------
AT&T Inc. (T) REPORT OVERVIEW
AT&T's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, AT&T reported revenue of $39,668.00 vs
$40,890.00 (down 2.99%) and diluted earnings per share $0.49 vs
$0.54 (down 9.26%). For the twelve months ended December 31st, 2016
vs December 31st, 2015, AT&T reported revenue of $163,786.00 vs
$146,801.00 (up 11.57%) and diluted earnings per share $2.10 vs
$2.37 (down 11.39%). AT&T is expected to report earnings on
January 24th, 2018. The report will be for the fiscal period ending
December 31st, 2017. The reported EPS for the same quarter last
year was $0.66. The estimated EPS forecast for the next fiscal year
is $2.98 and is expected to report on January 24th, 2018.
To read the full AT&T Inc. (T) report, download it here:
http://Fundamental-Markets.com/register/?so=T
-----------------------------------------
Denbury Resources Inc. (DNR) REPORT
OVERVIEW
Denbury Resources' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Denbury Resources reported revenue of
$266.56 vs $253.99 (up 4.95%) and diluted earnings per share $0.00
vs -$0.06. For the twelve months ended December 31st, 2016 vs
December 31st, 2015, Denbury Resources reported revenue of $975.60
vs $1,257.56 (down 22.42%) and diluted earnings per share -$2.61 vs
-$12.57. Denbury Resources is expected to report earnings on
February 22nd, 2018. The report will be for the fiscal period
ending December 31st, 2017. The reported EPS for the same quarter
last year was -$0.02. The estimated EPS forecast for the next
fiscal year is $0.12 and is expected to report on February 22nd,
2018.
To read the full Denbury Resources Inc. (DNR) report, download
it here:
http://Fundamental-Markets.com/register/?so=DNR
-----------------------------------------
Novavax, Inc. (NVAX) REPORT OVERVIEW
Novavax's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Novavax reported revenue of $8.35 vs $3.23
(up 158.50%) and diluted earnings per share -$0.15 vs -$0.24. For
the twelve months ended December 31st, 2016 vs December 31st, 2015,
Novavax reported revenue of $15.35 vs $36.25 (down 57.65%) and
diluted earnings per share -$1.03 vs -$0.60. Novavax is expected to
report earnings on February 26th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was -$0.21. The estimated EPS forecast for
the next fiscal year is -$0.54 and is expected to report on
February 26th, 2018.
To read the full Novavax, Inc. (NVAX) report, download it here:
http://Fundamental-Markets.com/register/?so=NVAX
-----------------------------------------
Immunomedics, Inc. (IMMU) REPORT OVERVIEW
Immunomedics' Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Immunomedics reported revenue of $0.69 vs
$0.74 (down 6.92%) and diluted earnings per share -$0.97 vs -$0.17.
For the twelve months ended June 30th, 2017 vs June 30th, 2016,
Immunomedics reported revenue of $3.09 vs $3.23 (down 4.39%) and
diluted earnings per share -$1.47 vs -$0.62. Immunomedics is
expected to report earnings on February 8th, 2018. The report will
be for the fiscal period ending December 31st, 2017. The reported
EPS for the same quarter last year was -$0.16. The estimated EPS
forecast for the next fiscal year is -$0.01 and is expected to
report on August 15th, 2018.
To read the full Immunomedics, Inc. (IMMU) report, download it
here:
http://Fundamental-Markets.com/register/?so=IMMU
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members
and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best
information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial
experience and includes top financial writers, FINRA® BrokerCheck®
certified professionals with current and valid CRD® number
designations, as well as Chartered Financial Analyst® (CFA®)
designation holders, to ensure up to date factual information for
active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff
are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Fundamental
Markets have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Fundamental Markets' Compliance
department by Phone, at +1 667-401-0010, or by E-mail at
compliance@fundamental-markets.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets
affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no
representations as to the completeness, accuracy, or timeliness of
the material provided and all materials are subject to change
without notice. Fundamental Markets has not been compensated for
the publication of this press release by any of the above mentioned
companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any
activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our
website.
Media Contact: Andrew Duffie, Media Department
Office: +1 667-401-0010 E-mail:
andrew.duffie@fundamental-markets.com
Ⓒ 2017 Fundamental Markets. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
General Motors (NYSE:GM)
Historical Stock Chart
From Mar 2024 to Apr 2024
General Motors (NYSE:GM)
Historical Stock Chart
From Apr 2023 to Apr 2024